02-02-2009: Saltigo GmbH has demonstrated its wide-ranging expertise in the fields of synthesis optimization and process development. The global specialist for exclusive custom synthesis has succeeded in increasing capacity for an active ingredient precursor for a major pharmaceutical manufacturer without needing to halt or interrupt the production process in any way. The project involved raising the output of a plant in Leverkusen from 30 metric tons a year to an urgently required 50 tons - under ongoing production.
Dr. Carsten Hesse, head of Manufacturing Strategy in the Pharma business line says: "It was absolutely essential to maintain reliable supplies of the product for our customer during the expansion phase. Because this project involved a complex, multi-step synthesis with very tight specifications and high quality requirements, it needed exceedingly accurate planning. The new connections and the re-routing of the apparatus were prepared so precisely that the output of the overall chain was not interrupted." The measures led to process and plant optimization and to a speeding up of the analytical procedures accompanying the process. Furthermore, it resulted in a near doubling of the capacity.
LANXESS announced a price increase for its Baypren branded Chloroprene business line of up to EUR 180 EUR / 240 USD per metric ton on a global basis. Reason being the since early 2012 again increasing raw material and energy prices amidst a tightening market for the respective feedstocks. S ... more
Specialty chemicals company LANXESS will be able to welcome employees, customers and guests to the “LANXESS Tower” from the middle of next year. This is the new name chosen for the company's future headquarters on Deutzer Freiheit in Cologne.
In summer 2011, LANXESS asked its employees to h ... more
LANXESS is continuing to expand its Indian production site in Jhagadia, Gujarat state. The specialty chemicals group is underlining its commitment to the subcontinent by inaugurating three new plants this month to serve the growing India market. LANXESS has invested over EUR 70 million and ... more
LANXESS is Germany’s largest listed specialty chemicals group and operates in all important markets of the world. Its core business comprises the development, manufacture and sale of high-tech plastics, high-performance rubber, specialty chemicals and intermediates. In addition, it helps it ... more
LANXESS is listed as the fourth largest German Chemistry Corporation in the Frankfurt Stock Exchange. With our extensive portfolio we are active in all the markets of the world. Our product pallet ranges from base, specialty and fine chemicals to plastics and rubbers. In addition, we sup ... more
LANXESS Sybron Chemicals Inc., provides world-class ion exchange resins to meet the needs of numerous applications. The global strength of Lewatit ion exchange resins in industrial water and chemical processing markets is joined with the solid position Ionac ion exchange resins enjoy in the ... more
Effective February 1, 2012, Joerg Schneider, Managing Director of LANXESS Elastômeros do Brasil S.A., will assume management of the Agro & Fine Chemicals business line of Saltigo GmbH. The 49-year-old will succeed Dr. Uwe Brunk, who is leaving the company at his own request. Schneider began ... more
Palladium-catalyzed cross-coupling reactions have become an important cornerstone of modern organic synthesis chemistry. They have made a wide variety of active pharmaceutical ingredients, natural substances and other complex organic molecules economically accessible. The award of this year ... more
Saltigo GmbH, the specialist in custom synthesis based in Langenfeld, Germany, and Reuter Chemische Apparatebau KG (RCA) of Freiburg, Germany, concluded a cooperation agreement on October 1. The companies will jointly develop processes for the synthesis of active pharmaceutical ingredients ... more
Saltigo GmbH is a globally operating custom manufacturing specialist, providing services in the pharmaceutical, agro- & specialty chemical industry. Saltigo combines the flexibility of a midsize company with the financial stability and coverage of a global player.
With a comprehensive set ... more